TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

BACKGROUND: Before antiretroviral therapy (ART) became widely available in sub-Saharan Africa, several studies demonstrated that daily trimethoprim-sulfamethoxazole (TS) prophylaxis reduced morbidity and mortality among HIV-infected adults. As a result, the World Health Organization (WHO) recommende...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Laurens, Matthew B., Mungwira, Randy G., Nyirenda, Osward M., Divala, Titus H., Kanjala, Maxwell, Muwalo, Francis, Mkandawire, Felix A., Tsirizani, Lufina, Nyangulu, Wongani, Mwinjiwa, Edson, Taylor, Terrie E., Mallewa, Jane, Blackwelder, William C., Plowe, Christopher V., Laufer, Miriam K., van Oosterhout, Joep J.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950772/
https://ncbi.nlm.nih.gov/pubmed/27431995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1392-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares